U.S. Auto Components Stock News

Vanda Pharmaceuticals stock barely budged after earnings, up about 0.5% to around US$5, even though the quarter underscored how hard the current build out is hitting the income statement. The headline is simple: revenue held around US$50.5m while the Q2 net loss widened to US$62.5m as spending on late stage trials and new launches weighed heavily. Investors came into this print after a tough stretch, with the stock down about 20% over the past month. The key question now is how long the...

Fastly stock has delivered a sharp rerating over the past year, yet the current valuation checks point to a company that screens as expensive rather than a clear bargain. Fastly has returned 204.0% over the past year, which puts more pressure on today’s buyers to justify the higher entry price. The company’s role in Experian’s Agent Trust ecosystem can support growth expectations around AI related traffic, while any disappointment in monetizing this kind of partnership may weigh heavily on...

Traders nudged Editas Medicine up about 5% today, which looks like a cautious, rather than euphoric, vote on a tricky set of numbers. The stock came into this report under pressure over the past month, so even a small relief move matters. The headline is margin pain meeting revenue progress. Total revenue for the quarter sat at US$11.89 million while the company still reported a loss with basic earnings per share at US$0.15 in the red. The real question now is whether this mix justifies...

Rigetti Computing (RGTI) is back in focus after its second quarter 2026 earnings report, which combined strong year over year revenue growth with a wider loss and several high profile quantum computing partnership updates. See our latest analysis for Rigetti Computing. Rigetti Computing’s share price has fallen 30% year to date, even after an 11% 7 day share price return following the earnings release and recent government and HPE partnership announcements, while the 3 year total shareholder...

Leggett & Platt recently reported its second-quarter 2026 results, with sales of US$999.7 million and net income of US$47.1 million, both lower than a year earlier, and declared a third-quarter dividend of US$0.05 per share payable on August 24, 2026. The combination of softer revenue and earnings for both the quarter and first half of 2026 highlights ongoing pressure on profitability despite the continued dividend payout. With second-quarter sales and earnings declining year over year,...

Sandisk stock closed down 6.8% at US$1,258.58, capping a tough month for holders after a double digit slide over 30 days. That reaction sits awkwardly next to a quarter where revenue hit US$8.97b and non GAAP earnings per share jumped to US$39.25, both ahead of management guidance. The real focus is not today’s drop but what this earnings release suggests about the multi year arc. Sandisk has moved from losses to a full year of profit and now trades on a trailing P/E of 16.4x, while a...

NASB Financial slipped about 1% today, even though the latest quarter showed the kind of earnings power many regional banks would welcome. Basic earnings per share for Q3 landed at roughly US$1.48 on revenue of about US$24.8 million, contributing to a trailing 12 month P/E of 8.4x that currently sits below the broader US banks sector and wider market. For short term traders the red screen might stand out. For longer term investors the focus is on the sustained profitability and the relatively...

Expedia Group just served up the kind of quarter that usually earns a celebration, yet the stock slipped 4.1% to about US$306 after the report. The gap between the reaction and the results is striking. Revenue for Q2 came in at US$4.3b and adjusted EBITDA margin reached 25.9%, with management confident enough to lift full year margin expansion targets. Investors came into this print after a strong three month run in the stock. Today’s move suggests profit taking and nerves, while the earnings...

Allient just ripped 19.3% higher in a single session, and that kind of move always raises the same question: Is this emotion or earnings talking? Coming into the print, the stock was already on a tear over the past quarter, and the valuation looked stretched on a P/E that sat well above peers. The headline this time is profit power. Quarterly basic earnings per share reached about US$0.62 on revenue of roughly US$153.8m, with trailing net income roughly doubling over the past year and net...

BeOne Medicines (ONC) stock is in focus after the company reported second quarter 2026 earnings and raised its full year revenue and GAAP operating income guidance on 5 August 2026. See our latest analysis for BeOne Medicines. The latest earnings surprise and higher 2026 guidance appear to be feeding into BeOne Medicines' momentum, with a 30-day share price return of 6.75% and a 1-year total shareholder return of 10.56%. The 3-year total shareholder return of 66.63% reflects a stronger long...

Why Pegasystems stock is in focus after the latest FedRAMP move Pegasystems (PEGA) is back on investors’ radar after expanding its FedRAMP Class D Certified capabilities within Pega Cloud for Government, widening access to its AI-driven workflow and decisioning tools for U.S. federal agencies. See our latest analysis for Pegasystems. At a share price of US$31.67, Pegasystems has seen short term momentum pick up with a 7 day share price return of 5.46%, although the share price is still down...

In the second quarter of 2026, Americold Realty Trust, Inc. reported revenue of US$662.89 million but recorded a net loss of US$342.81 million, largely reflecting a very large impairment of long-lived assets. This swing from a small profit a year earlier to a sizeable loss, despite relatively steady sales, points to a significant reassessment of asset values rather than a sharp decline in underlying demand. We’ll now examine how this sizable impairment-driven loss affects Americold’s...

BioMarin Pharmaceutical (BMRN) has just released its second quarter 2026 results, giving investors fresh detail on how revenue, earnings and guidance are evolving after its rare disease expansion. See our latest analysis for BioMarin Pharmaceutical. BioMarin Pharmaceutical’s Q2 earnings release and raised guidance have come alongside a 13.69% 90 day share price return and a modest 3.38% year to date share price return, while the 3 year total shareholder return has declined 32.39%, showing...

In the past quarter, Perdoceo Education Corporation reported second-quarter 2026 results with revenue of US$213.36 million and net income of US$47.97 million, both higher than a year earlier, alongside an increase in diluted earnings per share from continuing operations to US$0.75. Across the first half of 2026, the company’s revenue rose to US$435.10 million and net income to US$101.92 million, underscoring stronger profitability and earnings per share improvements from continuing...

Remitly Global stock jumped 7.7% today to US$25.93. That move came as investors reacted to a quarter that put profitability, not just growth, in the spotlight. Q2 revenue reached US$495 million while net income excluding special items came in at US$205.9 million, which is a sharp shift for a digital remittance platform that has spent years focused on scale. The main story is margin strength. Trailing net profit margin now sits at 16.9%, a significant increase from last year. The key question...

Why Horace Mann Educators Stock Is Back on Investors’ Radar Horace Mann Educators (HMN) has drawn fresh attention after reporting second quarter 2026 revenue of US$443.5 million and net income of US$41.6 million, with higher figures also reported for the first half of the year. See our latest analysis for Horace Mann Educators. The earnings update appears to have coincided with stronger interest in Horace Mann Educators, with the share price at US$54.12 and a 90 day share price return of...

In recent days, Autodesk has attracted heightened investor attention ahead of its 27 August 2026 earnings release, with analysts expecting year-over-year growth in both earnings per share and revenue. This focus on stronger anticipated earnings and sales underscores how closely investors are watching analyst forecasts as a gauge of Autodesk's operating momentum. With analysts projecting meaningful earnings and revenue growth, we'll now examine how this optimism could influence Autodesk's...

Novanta stock just jumped 6.7% in a single session, and that move highlights how emotionally charged this earnings season has become. The market responded to a clear headline of double digit revenue growth in Q2 and an increase to full year guidance. Beneath the excitement, the key drivers were margins and cash. Adjusted gross margin reached 47% and adjusted earnings per share rose at a double digit rate, while free cash flow for the quarter was about US$65 million. For a high multiple...

Huntsman (HUN) has drawn investor attention after reporting second quarter 2026 results along with a fresh dividend declaration. The update combines higher reported sales with a much smaller net loss and a continued cash payout. See our latest analysis for Huntsman. Despite the narrower loss and the continued dividend, Huntsman’s recent share price momentum has been weak, with a 7 day share price return down 16% and a 90 day share price return down 32%. Over a longer horizon, total...

Why Butterfly Network Stock Is Back on Investors’ Radar Butterfly Network (BFLY) is drawing fresh attention after raising its 2026 revenue outlook to US$119 million to US$123 million and issuing higher guidance for the third quarter following its latest earnings report. See our latest analysis for Butterfly Network. Butterfly Network’s raised guidance and stronger recent earnings sit alongside sharp share price momentum, with the stock posting a 30 day share price return of 9.5% and a 1 year...

With fresh US tariffs on imported polysilicon and new incentives for domestic production, the quiet world of semiconductor materials has suddenly moved to center stage. This policy shift could reshape where critical inputs for chips and solar panels are sourced, which matters for investors watching supply chains and pricing power. This article walks through 3 US semiconductor materials stocks exposed to this news and how each might fit, or might not fit, in a portfolio. The stocks highlighted...

Alpha Teknova stock rose 16.4% to close at US$6.53, capping a strong week for investors who were already sitting on solid short term gains. The market is focusing on one key development above all else. The headline result is that Q2 delivered the highest quarterly revenue in the company’s history, with more than US$12 million in sales and a clear step down in the quarterly net loss. That combination of record revenue and a narrower loss appears to have driven today’s shift in sentiment. The...

AbCellera Biologics jumped 10.3% to US$6.53 today, a sharp move for a stock that came into the print with a mixed recent run, up over the past week but down over the past month. The market is reacting to one thing above all else: the company is leaning hard into a high cash burn and deeper quarterly loss to fund its antibody pipeline, backed by a reported US$567 million cash pile and more than US$675 million of available liquidity. The question now is whether that liquidity cushion really...

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against its longer term returns and current fundamentals. See our latest analysis for Novo Nordisk. That jump in Novo Nordisk’s share price over the last session sits against a weaker backdrop, with the 7 day share price return down 10.93% and the year to date share price return down 12.25%. The 1 year total shareholder return is down 2.61%...